SAN JOSE, Calif.--(BUSINESS WIRE)--Lambda, the GPU cloud company founded by AI engineers and powered by NVIDIA GPUs, today announced that Iambic Therapeutics, a clinical-stage biotechnology company developing novel therapeutics using its unique AI-driven discovery platform, has selected Lambda Cloud to provide NVIDIA H100 Tensor Core GPUs to accelerate training and inference for its leading generative AI drug discovery models..

加利福尼亚州圣何塞——（商业新闻短讯）——Lambda是一家GPU云公司，由人工智能工程师创建，由NVIDIA GPU提供支持，今天宣布，Iambic Therapeutics是一家临床阶段的生物技术公司，使用其独特的人工智能驱动的发现平台开发新型治疗药物，已选择Lambda cloud提供NVIDIA H100 Tensor Core GPU，以加速其领先的生成性人工智能药物发现模型的培训和推理。。

“As we work to continuously search chemical space for potential molecules that may one day treat disease, there is a need for immense amounts of reliable computing power to support our current models and enable Iambic to continuously innovate. Lambda was able to create a custom cluster to meet our compute needs, provide key engineering expertise, and has demonstrated an ability to rapidly scale to meet our near-term requirements,” said Matt Welborn, Iambic’s Director of Machine Learning..

Iambic机器学习主管马特·韦尔伯恩（Matt Welborn）表示：“随着我们不断寻找化学空间中可能有一天会治疗疾病的潜在分子，我们需要大量可靠的计算能力来支持我们目前的模型，并使Iambic能够不断创新。Lambda能够创建一个定制集群来满足我们的计算需求，提供关键的工程专业知识，并证明了快速扩展以满足我们近期需求的能力。”。。

Iambic’s generative AI drug discovery models include NeuralPLexer, a state-of-the-art model for predicting protein-ligand structures, including conformation changes resulting from drug interactions. Predictions from NeuralPLexer and Iambic’s suite of models are served to Iambic’s integrated AI and high throughput experimental chemistry and biology labs, where thousands of unique molecules are synthesized and assayed every week..

Iambic的生成性AI药物发现模型包括NeuralPLexer，这是一种用于预测蛋白质-配体结构的最先进模型，包括由药物相互作用引起的构象变化。来自NeuralPLexer和Iambic的一套模型的预测被提供给Iambic的集成AI和高通量实验化学和生物学实验室，在那里每周合成和分析数千种独特的分子。。

“At Lambda, we’re committed to solving difficult compute challenges for customers across industries. Enabling transformer models in drug discovery efforts is an important step toward unlocking AI’s potential for advancing therapeutics,” said Stephen Balaban, Lambda CEO and co-founder. “We’re thrilled to collaborate with Iambic as they discover new medicines and look forward to working with more companies reimagining their endeavors through powerful AI and GPU compute access.”.

Lambda首席执行官兼联合创始人斯蒂芬·巴拉班（StephenBalaban）表示：“在Lambda，我们致力于为各个行业的客户解决困难的计算挑战。在药物发现工作中启用变压器模型是释放人工智能在推进治疗学方面潜力的重要一步。”。“我们很高兴与Iambic合作，因为他们发现了新药，并期待着与更多公司合作，通过强大的人工智能和GPU计算访问重新想象他们的努力。”。

Iambic joins leading global companies and research institutions like Anyscale, Sony, Rakuten, The AI Institute, and more in adopting Lambda Cloud. Lambda, an early provider of NVIDIA H100 GPUs, serves thousands of customers across manufacturing, healthcare, pharmaceuticals, financial services, and the U.S.

Iambic加入了领先的全球公司和研究机构，如Anyscale、Sony、Rakuten、AI Institute等，采用了Lambda云。Lambda是NVIDIA H100 GPU的早期供应商，为制造业、医疗保健、制药、金融服务和美国的数千名客户提供服务。

government. Lambda’s high-speed interconnect allows for training and fine-tuning of AI models on a cloud built for AI workloads - delivering a fast, cost-efficient, and easy-to-use GPU cloud for engineers achieving breakthrough innovations and enabling the next generation of tech..

政府。Lambda的高速互连允许在为AI工作负载构建的云上训练和微调AI模型-为工程师提供快速，经济高效且易于使用的GPU云，以实现突破性创新并实现下一代技术。。

Click here to learn more about Lambda’s cloud offerings for AI training and inference.

单击此处了解有关Lambda为人工智能培训和推理提供的云服务的更多信息。

About Lambda

关于Lambda

Lambda was founded in 2012 by AI engineers with published research at the top machine learning conferences in the world. Our goal is to become the #1 AI compute platform serving developers across the entire AI development lifecycle. We enable AI engineers to easily, securely and affordably build, test and deploy AI products at scale.

Lambda成立于2012年，由人工智能工程师在世界顶级机器学习会议上发表研究成果。我们的目标是成为在整个AI开发生命周期中为开发人员服务的#1 AI计算平台。我们使人工智能工程师能够轻松、安全、经济地大规模构建、测试和部署人工智能产品。

Our product portfolio spans from on-prem GPU hardware to hosted GPUs in the cloud. Lambda’s mission is to create a world where access to computation is as effortless and ubiquitous as electricity..

我们的产品组合涵盖从prem GPU硬件到云中托管GPU。Lambda的使命是创造一个像电力一样轻松、无处不在的计算世界。。

About Iambic Therapeutics

关于抑扬格疗法

Founded in 2019 and headquartered in San Diego, California, Iambic Therapeutics is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform. Iambic has assembled a world-class team that unites pioneering AI experts and experienced drug hunters with strong track records of success in delivering clinically validated therapeutics.

Iambic Therapeutics成立于2019年，总部位于加利福尼亚州圣地亚哥，凭借其独特的人工智能驱动的药物发现平台，正在颠覆治疗学的格局。Iambic组建了一个世界级的团队，该团队将领先的人工智能专家和经验丰富的药物猎手团结在一起，在提供临床验证治疗方面取得了良好的成功记录。

The Iambic platform has been demonstrated to deliver high-quality, differentiated therapeutics to clinical stage with unprecedented speed and across multiple target classes and mechanisms of action. The Iambic team is advancing an internal pipeline of clinical assets to address urgent unmet patient needs.

Iambic平台已被证明可以以前所未有的速度，跨越多个目标类别和作用机制，为临床阶段提供高质量，差异化的治疗方法。Iambic团队正在推进临床资产的内部管道，以解决紧急未满足的患者需求。

Learn more about the Iambic team, platform, and pipeline at iambic.ai..

在Iambic.ai了解更多关于Iambic团队、平台和管道的信息。。